CD8A and Miyoshi myopathy: Interestingly, MM patients treated with MV-NIS showed a significant increase in CD3+ T cells post-virotherapy compared with pre-virotherapy levels, and this was largely due to an increase in CD8+ T cells with no change observed in CD4+ T cells, nor in regulatory T cells (Fig. 6a).